Anticholinesterase effect of sotalol.
D000009:Abdominal Muscles / Q000187:drug effects; D000109:Acetylcholine / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D066298:In Vitro Techniques; D008790:Metoprolol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D010830:Physostigmine / Q000494:pharmacology; D011217:Practolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011898:Ranidae; D013015:Sotalol / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D002800:Cholinesterase Inhibitors; D002217:Carbachol; D010830:Physostigmine; D011433:Propranolol; D013015:Sotalol; D008790:Metoprolol; D000109:Acetylcholine; D011217:Practolol